Docking and Molecular Dynamics Study on the Inhibitory Activity of Novel Inhibitors on Epidermal Growth Factor Receptor (EGFR)

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|7|1|24-31

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.7, Iss.1, 2011-01, pp. : 24-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QSAR and Molecular Docking Studies on a Series of Cinnamic Acid Analogues as Epidermal Growth Factor Receptor (EGFR) Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 1, 2017-01 ,pp. : 83-95

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitory Activity Against Epidermal Growth Factor Receptor (EGFR) Based on Single Point Mutations of Active Site Residues

By  

Medicinal Chemistry, Vol. 10, Iss. 3, 2014-05 ,pp. : 252-270

Bentham Science Publishers

Access to resources Recommend Favorite

Acneiform folliculitis associated with epidermal growth factor receptor (EGFR) inhibitors requires sympathetic treatment of mild, as well as severe, symptoms

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 6, 2009-06 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite

The risk of keratitis previously identified with panitumumab is now considered a class effect for all epidermal growth factor receptor (EGFR) inhibitors

By  

Reactions Weekly, Vol. 1, Iss. 1405, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Predictive Molecular Markers of Response to Epidermal Growth Factor Receptor(EGFR) Family-Targeted Therapies

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 799-812

Bentham Science Publishers

Access to resources Recommend Favorite